<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://newsletter.glp1studio.com/p/compounded-tirzepatide-vials-recalled</loc><news:news><news:publication><news:name>GLP-1 Studio</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-21T17:00:00+00:00</news:publication_date><news:title>Compounded tirzepatide vials recalled over sterility concerns</news:title></news:news></url><url><loc>https://newsletter.glp1studio.com/p/high-dose-semaglutide-starts-are</loc><news:news><news:publication><news:name>GLP-1 Studio</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-21T17:00:00+00:00</news:publication_date><news:title>High-dose semaglutide starts are linked to earlier discontinuation</news:title></news:news></url></urlset>